.jpg) |
| The Third Boao International Conference on Real World Studies of Medical Products |
BOAO, China, Dec 2 , 2024 /Xinhua-AsiaNet/--
The third Boao International Conference on Real World Studies of Medical Products was successfully held from November 23 to 24 in Boao, Hainan Province, China. The event attracted over 800 participants, including representatives from international organizations, regulatory agencies for drugs and medical devices, prominent medical institutions, top research institutes and universities, and multinational pharmaceutical and medical device companies.
In recent years, real-world studies have garnered widespread attention from regulatory agencies worldwide for their critical role in the evaluation and approval of drugs and medical devices. In addition, real-world data has increasingly been recognized as a key resource in supporting regulatory decision-making globally.
As a pivotal platform for international exchange in the field of real-world studies, both in China and globally, the Boao International Conference on Real-World Studies of Medical Products has been successfully held for three consecutive years.
Organized by the Hainan Lecheng Institute of Real World Study, this year's conference centered on the theme "Real-World Studies Facilitate Clinical Evaluation of Innovative Drugs and Medical Devices." The program featured a plenary session and seven thematic sessions：(1) RWS and Clinical Evaluation of Drugs; (2) RWS and Clinical Evaluation of Medical Devices; (3) RWS and Pharmacovigilance; (4) RWS and Biostatistics; (5) RWS and Information Technologies; (6) RWS and Rare Diseases; (7) RWS and Clinical Evaluation of TCM. The conference served as a vital platform for sharing insights into regulatory science and showcasing advanced research, fostering industry growth.
In recent years, real-world studies have garnered widespread attention from regulatory agencies worldwide for their critical role in the evaluation and approval of drugs and medical devices. In addition, real-world data has increasingly been recognized as a key resource in supporting regulatory decision-making globally.
As a pivotal platform for international exchange in the field of real-world studies, both in China and globally, the Boao International Conference on Real-World Studies of Medical Products has been successfully held for three consecutive years.
Organized by the Hainan Lecheng Institute of Real World Study, this year's conference centered on the theme "Real-World Studies Facilitate Clinical Evaluation of Innovative Drugs and Medical Devices." The program featured a plenary session and seven thematic sessions：(1) RWS and Clinical Evaluation of Drugs; (2) RWS and Clinical Evaluation of Medical Devices; (3) RWS and Pharmacovigilance; (4) RWS and Biostatistics; (5) RWS and Information Technologies; (6) RWS and Rare Diseases; (7) RWS and Clinical Evaluation of TCM. The conference served as a vital platform for sharing insights into regulatory science and showcasing advanced research, fostering industry growth.
No comments:
Post a Comment